
(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Tire Brands for Senior Drivers: Guaranteeing Security and Solace - 2
Instructions to Arrange Your Compensation During Medical caretaker Prospective employee meetings - 3
Figure out how to Put resources into Lab Precious stones: A Novice's Aide - 4
Embracing Practical Living and Ecological Protection - 5
Chinese mega embassy could bring security advantages, says No 10
4 astronauts are now on their path to the moon. Here’s what happens next
The many ways that baking is winter therapy. With a delicious ending
'The Housemaid' movie with Sydney Sweeney and Amanda Seyfried premieres this month. What the stars have said about the psychological thriller.
Seven deaths possibly linked to malfunctioning glucose monitors
7 Logically Demonstrated Techniques for Better Rest
Witness the elegance of the cosmic butterfly in a remarkable telescope photo
MEPs urge Commission leaders to stop Russia from returning to the Venice Biennale
New movies to watch this weekend: See 'Wake Up Dead Man: A Knives Out Mystery' in theaters, rent 'Bugonia,' stream 'Caught Stealing' on Netflix
Study casts doubt on potential for life on Jupiter's moon Europa












